I meant if the drug is commercialised i.e. is successfully brought to market. We still have multiple important milestones to pass before we get there though such as a successful trial and partnership. There is no guarantee that this drug will get there but that is the risk we take. IF the drug gets to market and we start producing revenue close to the targets suggested in the presentation, $1-$2 is fair value. I don't think that is too far fetched.
This is my opinion so DYOR.
I meant if the drug is commercialised i.e. is successfully...
-
- There are more pages in this discussion • 322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 250808 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 312804 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |